8:30am ET
Health and Healthcare
Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough
Johnson & Johnson released better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Chris Lange
Companies
/Healthcare
Johnson & Johnson
$270.22
▲ $2.94 (+1.10%) today
Markets closed · 11:22pm ET
JNJ Coverage
Page 45 Chris Lange 9:35am ET
Investing
7 of This Week’s Most-Anticipated Earnings Reports
Now that the fourth-quarter earnings reporting season has kicked off, more major companies will be sharing their results this week, including Comcast, Ford and Intel.
9:20am ET
Investing
Boeing and J&J Both Offer New Incentives for Investors After Big Losses
These two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back.
11:35am ET
Health and Healthcare
Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Chris Lange 6:45am ET
Investing
High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018
Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been.
11:00am ET
Investing
After the Midterm Elections, 10 Defensive Stocks to Buy for 2019
These 10 companies that are likely to have safer business models and will offer some defensive positioning if the economic strength of 2018 is not repeated in 2019.
8:35am ET
Health and Healthcare
Should Johnson & Johnson Be Getting More Out of Q3 Earnings?
Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.
Chris Lange 10:15am ET
Health and Healthcare
What to Expect When Johnson & Johnson Reports Tuesday
Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the top and bottom lines.
Chris Lange 7:10am ET
Investing
Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week
24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones industrial average companies scheduled to report their quarterly results this week.
11:40am ET
Health and Healthcare
Why Arrowhead Pharma’s New Agreement Is a Big Deal
Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
Chris Lange 4:01pm ET
Investing
Intel, UnitedHealth Sink the Dow Tuesday
Intel, UnitedHealth, Johnson & Johnson, and 3M Company led the Dow's Tuesday drop.
4:01pm ET
Investing
Visa, Microsoft Hold Back the Dow Wednesday
Trading in the Dow 30 stocks was essentially flat Wednesday with Visa and Microsoft the leading losers while Caterpillar and Johnson & Johnson gained the most.
4:01pm ET
Investing
Nike, Johnson & Johnson Lift the Dow Monday
Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.
5:35pm ET
Investing
Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings
The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional Buffett picks.
10:30am ET
Investing
The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club
It may not happen overnight, and a solid market correction would almost certainly interfere, but there are many companies that may be chasing that $1 trillion milestone.